Skip to main content

OptiNose, Inc.

OPTNDelisted May 21, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001494650

OptiNose, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 21, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $65.6M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding OptiNose, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of OPTN: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders65149−15
Shares22.7M156.8K20.8M−1.68M (−7.5%)
Value$70.5M$488.0K$62.5M−$7.52M (−10.7%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held OptiNose, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to OPTN in Q3 2021
InstitutionSharesValue% of portfolio
Easterly Investment Partners LLC343,385$1.03M0.07%
Bank of Montreal111,400$339.0K0.00%
Citadel Advisors LLC17,829$53.0K0.00%
Parametric Portfolio Associates LLC11,392$34.0K0.00%
Group One Trading, L.P.500$2.00K0.00%

Sold out (20)

Institutions that held OptiNose, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.

Not filed for Q3 2021 yet (1)

Institutions that held OptiNose, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OPTN in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Snow Capital Management LP156,810$488.0K